EPKINLY
epcoritamab-bysp
- Strength
- 48 mg/.8mL
- Form
- Injection, Solution
- Class
- Bispecific CD20-directed CD3 T Cell Eng…
Genmab US, Inc.
Not stocked by us — reference only
epcoritamab-bysp
Listed by Genmab US, Inc.
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Bispecific CD20-directed CD3 T Cell Engager |
| Approval route | BLA — biologic licence |
| NDC code | 82705-002 |
| FDA application | BLA761324 |
| RxNorm concept | 2637399 |
| Package sizes listed | 1 |
| Marketed since | May 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
epcoritamab-bysp
Genmab US, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.